Puneet Souda
Stock Analyst at Leerink Partners
(1.58)
# 3,292
Out of 4,944 analysts
215
Total ratings
47.43%
Success rate
-1.51%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Upgrades: Outperform | $16 | $9.08 | +76.21% | 7 | Aug 6, 2025 | |
| MASS 908 Devices | Upgrades: Outperform | $12 | $7.05 | +70.21% | 7 | Aug 5, 2025 | |
| QTRX Quanterix | Downgrades: Market Perform | $12 → $8 | $4.79 | +67.01% | 12 | Apr 30, 2025 | |
| NEO NeoGenomics | Downgrades: Market Perform | $25 → $9 | $6.24 | +44.23% | 10 | Apr 30, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | $80 → $75 | $68.98 | +8.73% | 7 | Feb 6, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $5.87 | +257.75% | 7 | Dec 9, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $30.68 | +30.38% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $157.70 | -4.88% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $296.83 | +26.33% | 15 | Aug 1, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $630 | $484.79 | +29.95% | 19 | Jul 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $35 | $19.41 | +80.32% | 11 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $145 | $120.29 | +20.54% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $209.14 | +43.44% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $101.11 | +147.26% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $54.71 | +101.06% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $44.91 | +67.00% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $127.15 | +57.29% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $4.58 | +293.01% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $2.05 | +192.68% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $28.65 | +4.71% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $34.54 | +151.88% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $58.57 | +139.03% | 5 | Feb 24, 2022 |
Cryoport
Aug 6, 2025
Upgrades: Outperform
Price Target: $16
Current: $9.08
Upside: +76.21%
908 Devices
Aug 5, 2025
Upgrades: Outperform
Price Target: $12
Current: $7.05
Upside: +70.21%
Quanterix
Apr 30, 2025
Downgrades: Market Perform
Price Target: $12 → $8
Current: $4.79
Upside: +67.01%
NeoGenomics
Apr 30, 2025
Downgrades: Market Perform
Price Target: $25 → $9
Current: $6.24
Upside: +44.23%
Hologic
Feb 6, 2025
Downgrades: Market Perform
Price Target: $80 → $75
Current: $68.98
Upside: +8.73%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $5.87
Upside: +257.75%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $30.68
Upside: +30.38%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $157.70
Upside: -4.88%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $296.83
Upside: +26.33%
Thermo Fisher Scientific
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $484.79
Upside: +29.95%
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $19.41
Upside: +80.32%
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $120.29
Upside: +20.54%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $209.14
Upside: +43.44%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $101.11
Upside: +147.26%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $54.71
Upside: +101.06%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $44.91
Upside: +67.00%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $127.15
Upside: +57.29%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $4.58
Upside: +293.01%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $2.05
Upside: +192.68%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $28.65
Upside: +4.71%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $34.54
Upside: +151.88%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $58.57
Upside: +139.03%